IQVIA Holdings Inc. (IQV) stock
IQVNYSEServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 9/3014% above fair value
$257.60−7.13 (-2.69%)
Close on Nov 17, 2026Market cap $42.45BP/E 31.3Yield –
Iqvia cash
Cash and short-term investments held at the end of each period.
Iqvia's cash was $2.42B at Sep 30, 2026. For fiscal 2025 it was $2.14B, up 16.2% from the year before. Over ten years it grew 8.2% a year on average. The highest annual figure on record is $2.14B in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.14B | +16.2% |
| FY2024 | Dec 31, 2024 | $1.84B | +23.2% |
| FY2023 | Dec 31, 2023 | $1.50B | +14.3% |
| FY2022 | Dec 31, 2022 | $1.31B | -11.4% |
| FY2021 | Dec 31, 2021 | $1.48B | -22.3% |
| FY2020 | Dec 31, 2020 | $1.90B | +111.6% |
| FY2019 | Dec 31, 2019 | $899.00M | -4.2% |
| FY2018 | Dec 31, 2018 | $938.00M | -6.7% |
| FY2017 | Dec 31, 2017 | $1.01B | -18.8% |
| FY2016 | Dec 31, 2016 | $1.24B | +26.7% |
| FY2015 | Dec 31, 2015 | $977.00M | +12.7% |
| FY2014 | Dec 31, 2014 | $867.00M | +11.6% |
| FY2013 | Dec 31, 2013 | $777.00M | +36.9% |
| FY2012 | Dec 31, 2012 | $567.73M | +10.0% |
| FY2011 | Dec 31, 2011 | $516.30M | -20.2% |
| FY2010 | Dec 31, 2010 | $646.62M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $2.42B | +22.8% |
| Q2 FY2026 | Jun 30, 2026 | $2.08B | -4.9% |
| Q1 FY2026 | Mar 31, 2026 | $2.10B | +12.1% |
| Q4 FY2025 | Dec 31, 2025 | $2.14B | +16.2% |
| Q3 FY2025 | Sep 30, 2025 | $1.97B | +15.2% |
| Q2 FY2025 | Jun 30, 2025 | $2.19B | +30.4% |
| Q1 FY2025 | Mar 31, 2025 | $1.88B | +19.1% |
| Q4 FY2024 | Dec 31, 2024 | $1.84B | +23.2% |
| Q3 FY2024 | Sep 30, 2024 | $1.71B | +28.5% |
| Q2 FY2024 | Jun 30, 2024 | $1.68B | +12.5% |
| Q1 FY2024 | Mar 31, 2024 | $1.58B | -1.4% |
| Q4 FY2023 | Dec 31, 2023 | $1.50B | +14.3% |
| Q3 FY2023 | Sep 30, 2023 | $1.33B | -2.1% |
| Q2 FY2023 | Jun 30, 2023 | $1.49B | -1.7% |
| Q1 FY2023 | Mar 31, 2023 | $1.60B | +7.0% |
| Q4 FY2022 | Dec 31, 2022 | $1.31B | -11.4% |
| Q3 FY2022 | Sep 30, 2022 | $1.36B | -13.5% |
| Q2 FY2022 | Jun 30, 2022 | $1.52B | -20.6% |
| Q1 FY2022 | Mar 31, 2022 | $1.49B | -37.8% |
| Q4 FY2021 | Dec 31, 2021 | $1.48B | -22.3% |
| Q3 FY2021 | Sep 30, 2021 | $1.57B | +2.0% |
| Q2 FY2021 | Jun 30, 2021 | $1.91B | +61.7% |
| Q1 FY2021 | Mar 31, 2021 | $2.40B | +142.6% |
| Q4 FY2020 | Dec 31, 2020 | $1.90B | +111.6% |
| Q3 FY2020 | Sep 30, 2020 | $1.54B | +67.7% |
| Q2 FY2020 | Jun 30, 2020 | $1.18B | +18.9% |
| Q1 FY2020 | Mar 31, 2020 | $990.00M | -0.1% |
| Q4 FY2019 | Dec 31, 2019 | $899.00M | -4.2% |
| Q3 FY2019 | Sep 30, 2019 | $920.00M | +4.7% |
| Q2 FY2019 | Jun 30, 2019 | $994.00M | +7.1% |
| Q1 FY2019 | Mar 31, 2019 | $991.00M | -1.6% |
| Q4 FY2018 | Dec 31, 2018 | $938.00M | -6.7% |
| Q3 FY2018 | Sep 30, 2018 | $879.00M | -23.4% |
| Q2 FY2018 | Jun 30, 2018 | $928.00M | -1.8% |
| Q1 FY2018 | Mar 31, 2018 | $1.01B | +11.3% |
| Q4 FY2017 | Dec 31, 2017 | $1.01B | -18.8% |
| Q3 FY2017 | Sep 30, 2017 | $1.15B | – |
| Q2 FY2017 | Jun 30, 2017 | $945.00M | – |
| Q1 FY2017 | Mar 31, 2017 | $905.00M | – |
| Q4 FY2016 | Dec 31, 2016 | $1.24B | – |
See a number that looks wrong?